Neural Mechanisms for Stopping Ongoing Speech Production (Study 2)
2 other identifiers
interventional
12
1 country
1
Brief Summary
Speech and communication disorders often result in aberrant control of the timing of speech production, such as making improper stops at places where they should not be. During normal speech, the ability to stop when necessary is important for maintaining turn-taking in a smooth conversation. Existing studies have largely investigated neural circuits that support the preparation and generation of speech sounds. It is believed that activity in the prefrontal and premotor cortical areas facilitates high-level speech control and activity in the ventral part of the sensorimotor cortex controls the articulator (e.g. lip, jaw, tongue) movements. However, little is known about the neural mechanism controlling a sudden and voluntary stop of speech. Traditional view attributes this to a disengagement of motor signals while recent evidence suggested there may be an inhibitory control mechanism. This gap in knowledge limits our understanding of disorders like stuttering and aphasia, where deficits in speech timing control are among the common symptoms. The overall goal of this study is to determine how the brain controls the stopping of ongoing speech production to deepen our understanding of speech and communication in normal and impaired conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 14, 2026
CompletedFirst Posted
Study publicly available on registry
July 20, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2028
Study Completion
Last participant's last visit for all outcomes
July 31, 2028
July 20, 2026
July 1, 2026
1.9 years
July 14, 2026
July 14, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Mean Change in Neural Activity
Neural signal recorded at each electrode (measured in voltage) is bandpass-filtered and converted to analytic amplitude using Hilbert transform, and then Z-scored relative to the entire recording block period for that electrode. A Z-score of 0 represents the mean neural activity within the recording block period, during which the task is performed. A positive Z-score indicates higher neural activity compared to the block mean. The mean change in neural activity was calculated as the difference between the average Z-score in two time windows (\~1 second after the visual cue vs. \~1 second before), averaged across trials for each electrode and then across electrodes from all participants. Positive values of the mean change in neural activity indicate that neural activity was increased after the visual cue. Since the Z-score used here is a normalized neurophysiological measure rather than a clinical scale, there are no established thresholds or definitions of better or worse outcomes.
During inpatient hospitalization, up to 14 days after surgical electrode implantation
Study Arms (1)
Voice and iEEG recording during Speech Production Tasks
EXPERIMENTALInterventions
View visual cues and undergo speech production.
Eligibility Criteria
You may qualify if:
- Undergoing iEEG placement in regions of interest (e.g., in the frontal or temporal cortex) for clinically necessary localization of epileptic foci or language mapping
- Fluent English speakers
- Within the normal range for cognitive, speech-language, and hearing capacity
- Normal or corrected-to-normal visual acuity
You may not qualify if:
- Individuals with intellectual disability
- Lack of fluent English comprehension/production
- Inadequate speech ability for the research tasks.
- History of autism or ADHD
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UPMC Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, 15224, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lingyun Zhao, PhD
University of Pittsburgh
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 14, 2026
First Posted
July 20, 2026
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
July 31, 2028
Study Completion (Estimated)
July 31, 2028
Last Updated
July 20, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
IPD will not be shared due to privacy concerns associated with intracranial data.